IL6 and Alzheimer disease: In contrast, SMC, MCI and AD patient subjects have shown significantly less pro- and anti-inflammatory cytokine levels, with the exception only of IL-6 levels in the SMC group which remained the same as per healthy subjects (Supplementary Fig 4).